Geospace Technologies Corp: Form 10-Q for the period ended Jun 30, 2023
Filed with the SEC on Aug 11, 2023 and accepted by EDGAR at Aug 11, 2023, 11:51 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-04-01 to 2023-06-30 | $32.7m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2022-10-01 to 2023-06-30 | $95.2m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2023-04-01 to 2023-06-30 | $18.7m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months2022-10-01 to 2023-06-30 | $57.7m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2023-04-01 to 2023-06-30 | $14.0m | us-gaap:GrossProfit |
| Gross profit | 9 months2022-10-01 to 2023-06-30 | $37.5m | us-gaap:GrossProfit |
| Research and development | 3 months2023-04-01 to 2023-06-30 | $4.4m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2022-10-01 to 2023-06-30 | $12.1m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2023-04-01 to 2023-06-30 | $6.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2022-10-01 to 2023-06-30 | $19.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2023-04-01 to 2023-06-30 | $3.1m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2022-10-01 to 2023-06-30 | $7.2m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2023-04-01 to 2023-06-30 | $22.0k | us-gaap:InterestExpense |
| Interest expense | 9 months2022-10-01 to 2023-06-30 | $100.0k | us-gaap:InterestExpense |
| Income tax | 3 months2023-04-01 to 2023-06-30 | $219.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2022-10-01 to 2023-06-30 | $268.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-04-01 to 2023-06-30 | $3.2m | us-gaap:NetIncomeLoss |
| Net income | 9 months2022-10-01 to 2023-06-30 | $7.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-04-01 to 2023-06-30 | $0.24 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2022-10-01 to 2023-06-30 | $0.59 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-04-01 to 2023-06-30 | $0.25 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2022-10-01 to 2023-06-30 | $0.59 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-04-01 to 2023-06-30 | 13,320,881 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2022-10-01 to 2023-06-30 | 13,157,919 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2022-10-01 to 2023-06-30 | $3.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2022-10-01 to 2023-06-30 | $1.9m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 9 months2022-10-01 to 2023-06-30 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-06-30 | $27.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-06-30 | $76.4m | us-gaap:AssetsCurrent |
| Total assets | At period end2023-06-30 | $145.7m | us-gaap:Assets |
| Current liabilities | At period end2023-06-30 | $16.1m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-06-30 | $16.7m | us-gaap:Liabilities |
| Long-term debt | At period end2023-06-30 | $0 | us-gaap:LongTermDebt |
| Shareholders' equity | At period end2023-06-30 | $129.0m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001437749-23-023223. Last ingested by Listed: Nov 3, 2026, 09:38 ET. Listed shows no prices and gives no investment advice.